Popular on PrZen
- Home Run Pest & Termite Control Launches Monthly Mosquito Service to Help Wylie, Plano, and Rockwall Homeowners Reclaim Their Backyards - 299
- Students Celebrate Earth Month and Learn About the Lifecycle of Trees - 275
- Museum Hack Presents Hacked Gala: A Rebellious Night of Art, Fashion, and Change at the Met - 116
- American Mensa Welcomes 7-Year-Old Savannah Boy - 115
- Artist Séfora Camazano Honored with Prestigious Prize "The New Great Masters in New York" - 105
- Tobu Railway Announces a Price Revision on the "NIKKO PASS All Area" and "NIKKO PASS World Heritage Area," from April 20, 2025 - 104
- Guests Can Save 20 Percent on a Florida Keys Vacation Home Rental with KeysCaribbean's 'Last-Minute Booking Discount' - 103
- Damian Redd's "Caught in a Fantasy" Surpasses 100,000 Views on VEVO/YouTube Following Album Reissue - 103
- Webinar Announcement: Mexico's Evolving AML/CFT Environment: FATF Review and FTO Designations - 102
- Jayson Warner Smith joins the cast of Tulsa King, The Good Daughter and Murdaugh Murders in 2025
Similar on PrZen
- Therapy 911 Launches Mental Health Social Network to Celebrate Mental Health Awareness Month
- $7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Novel 'We Won't Go Back' Published; Addresses Women's Issues
- The ROS1ders Announces Recipients of 2024 ROS1+ Cancer Innovation Awards
- AUACOM Signs a Statement of Shared Interest with BMCC
- Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
- Tribeca Film Festival Official Podcast Selection Lead Features Hollywood Stars, Focuses On Ending Childhood Lead Poisoning In New York!
- $34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
- Pikmykid Launches $100,000 School Safety Grant Giveaway to Support K–12 Schools Across the U.S
- Mother's Day Wake-Up Call for Maternal Health: New Initiative Demands Better Postpartum Support
New York Times Exposé Vindicates CCHR: ADHD Isn't Biological, Says Watchdog
PrZen/33577745
Parents deserve the truth as leading scientists now admit families were misled into believing their children had a neurobiological disorder that required powerful stimulant prescriptions.
LOS ANGELES - PrZen -- A recent exposé in The New York Times Magazine will send shockwaves through the psychiatric community, affirming what the Citizens Commission on Human Rights International (CCHR) has warned for decades: there is no medical proof that Attention Deficit Hyperactivity Disorder (ADHD) is a biological disorder.[1] Yet, over 3.4 million American children are labeled with ADHD and prescribed powerful, mind-altering stimulants.
According to Jan Eastgate, President of CCHR International, the Times' revelations "should prompt federal lawmakers and public health officials to investigate how millions of children could be drugged under a false premise—and why dissenting voices were ignored."
The New York Times Magazine article by Paul Tough details how ADHD was long marketed as a neurobiological disorder requiring medication, despite lacking any objective test. Tough writes that the entire system rests on shaky assumptions: "that ADHD is a medical disorder that demands a medical solution; that it is caused by inherent deficits in children's brains; and that the medications we give them repair those deficits." But many of those once involved in building this narrative are now disowning it.
As the article concedes: "Unlike with diabetes, there is no reliable biological test for ADHD," and diagnosis often relies on "subjective judgment."
Eastgate underscores the damage: "Millions of parents were led to believe their children had a brain disorder—one that science now admits it cannot medically confirm. That's not mental healthcare. That's institutional betrayal."
Experts Retreat from ADHD's Scientific Foundation
Among the most striking revelations is the reversal of leading researchers who once championed the disorder and its treatments.
Dr. James Swanson, a research psychologist and one of ADHD's early proponents, was central to efforts in the 1990s that drove public acceptance of the diagnosis. At that time, CCHR was actively protesting the mass drugging of children, warning that the supposed science behind ADHD was fundamentally flawed. Their concerns are now echoed by Swanson himself.
After three decades of research, Swanson told The Times: "I don't agree with people who say that stimulant treatment is good. It's not good." He also found that children taking the drugs were still symptomatic years later and were shorter than their peers.
Other prominent scientists quoted include:
Sonuga-Barke went further, calling the search for a biological marker a "red herring," and admitting: "There literally is no natural cutting point where you could say, 'This person has got ADHD, and this person hasn't got it.' Those decisions are to some extent arbitrary."
The Human Toll: Why Kids Quit the Drugs
The exposé also reveals how teens themselves reject ADHD stimulants. Swanson notes the high dropout rate among young users—many of whom said the drugs made them feel worse. "If it's so effective, why do people stop?" he asked.
Eastgate responds: "For decades, parents were told by doctors, 'If you don't medicate your child, you're a bad parent.' But when children themselves report the drugs made them feel bad, it's psychiatry that refuses to listen."
In response to the widespread overuse of ADHD diagnoses and stimulant prescribing—even in children under five—the U.S. Department of Health and Human Services has launched a federal review. CCHR welcomes this as long overdue.
For over 40 years, CCHR has maintained that psychiatric labels such as ADHD are not rooted in biological science but are voted into existence through panels of psychiatrists—not discovered through medical testing. As far back as the 1980s and 1990s, CCHR was on record opposing the mass diagnosis of ADHD and the marketing of stimulants to schoolchildren.
"This investigation must look at how pseudoscience became policy," said Eastgate. "And why the system ignored watchdogs, parents, and even the United Nations, until some of the same researchers who created the mess began to admit their mistake."
In 2017, Dr. Dainius Pūras, a psychiatrist and then UN Special Rapporteur on the Right to Health, urged governments to move away from the biomedical (drug-based) model of mental health.[2] CCHR had already submitted evidence to the U.N. Committee on the Rights of the Child (UNCRC), documenting psychostimulant prescribing in 14 countries.
The UNCRC responded by recommending strict monitoring of ADHD drug use in children and criticized the "medicating" of children without addressing root causes or offering alternative supports.[3]
More recently, the World Health Organization and the Office of the U.N. High Commissioner for Human Rights jointly declared that "legislation on mental health must… move away from the narrow traditional 'biomedical paradigm.'"[4]
The New York Times exposé represents a landmark moment in pediatric mental health. It exposes how ADHD's "biological" foundations were misleading, and the harms of its treatments were undersold. CCHR says it validates what the group has long stood for: that millions of children were mislabeled and drugged.
"This is a reckoning," concludes Eastgate. "But it must become a reform. It's not enough to admit the science was wrong. The system must now be held accountable for what it did with that false science—and ensure it never happens again."
About CCHR: Mental health industry watchdog established in 1969 by the Church of Scientology and the late professor of psychiatry, Dr. Thomas Szasz. CCHR has achieved hundreds of reforms, including bans on minors being electroshocked and federal protections against forced drugging of schoolchildren.
Sources:
[1] Paul Tough, "Have We Been Thinking About A.D.H.D. All Wrong?" The New York Times Magazine, 13 Apr. 2025, www.nytimes.com/2025/04/13/magazine/adhd-medication-treatment-research.html?smid=em-share
[2] "World Needs 'Revolution' in Mental Health Care, U.N. Health Rights Expert Reports," CCHR International, 14 June 2017, www.cchrint.org/2017/06/14/world-needs-revolution-in-mental-health-care/; "World needs 'revolution' in mental health care – UN rights expert," United Nations, 6 June 2017, www.ohchr.org/en/press-releases/2017/06/world-needs-revolution-mental-health-care-un-rights-expert; web.archive.org/web/20170118053505/http://www.ohchr.org/EN/Issues/Health/Pages/SRBio.aspx
[3] "Consideration of reports submitted by States parties under article 44 of the Convention," UNCRC, 17 Sept. – 5 Oct. 2012, p. 15, web.archive.org/web/20130729192330/http://rightsofchildren.ca/wp-content/uploads/Canada_CRC-Concluding-Observations_61.2012.pdf
[4] "New WHO Mental Health Guideline Condemns Coercive Psychiatric Practices," CCHR International, 18 Sept. 2023, www.cchrint.org/2023/09/18/who-guideline-condemns-coercive-psychiatric-practices/; "Guidance on Mental Health, Human Rights and Legislation," World Health Organization, OHCHR, 9 Oct. 2023, p. xvii, iris.who.int/bitstream/handle/10665/373126/9789240080737-eng.pdf
According to Jan Eastgate, President of CCHR International, the Times' revelations "should prompt federal lawmakers and public health officials to investigate how millions of children could be drugged under a false premise—and why dissenting voices were ignored."
The New York Times Magazine article by Paul Tough details how ADHD was long marketed as a neurobiological disorder requiring medication, despite lacking any objective test. Tough writes that the entire system rests on shaky assumptions: "that ADHD is a medical disorder that demands a medical solution; that it is caused by inherent deficits in children's brains; and that the medications we give them repair those deficits." But many of those once involved in building this narrative are now disowning it.
As the article concedes: "Unlike with diabetes, there is no reliable biological test for ADHD," and diagnosis often relies on "subjective judgment."
Eastgate underscores the damage: "Millions of parents were led to believe their children had a brain disorder—one that science now admits it cannot medically confirm. That's not mental healthcare. That's institutional betrayal."
Experts Retreat from ADHD's Scientific Foundation
Among the most striking revelations is the reversal of leading researchers who once championed the disorder and its treatments.
Dr. James Swanson, a research psychologist and one of ADHD's early proponents, was central to efforts in the 1990s that drove public acceptance of the diagnosis. At that time, CCHR was actively protesting the mass drugging of children, warning that the supposed science behind ADHD was fundamentally flawed. Their concerns are now echoed by Swanson himself.
After three decades of research, Swanson told The Times: "I don't agree with people who say that stimulant treatment is good. It's not good." He also found that children taking the drugs were still symptomatic years later and were shorter than their peers.
Other prominent scientists quoted include:
- Edmund Sonuga-Barke, King's College London: "The traditional notion that there is a natural category of people with ADHD… just doesn't seem to be the case."
- John Gabrieli, MIT neuroscientist: "There is no single-gene story... now we realize how far away we are."
- William Pelham, Jr., University at Buffalo: "We found no [evidence that stimulants] translate into improved learning."
- F. Xavier Castellanos, NYU: ADHD drugs have "minimal effects on academic achievement or attainment."
Sonuga-Barke went further, calling the search for a biological marker a "red herring," and admitting: "There literally is no natural cutting point where you could say, 'This person has got ADHD, and this person hasn't got it.' Those decisions are to some extent arbitrary."
The Human Toll: Why Kids Quit the Drugs
The exposé also reveals how teens themselves reject ADHD stimulants. Swanson notes the high dropout rate among young users—many of whom said the drugs made them feel worse. "If it's so effective, why do people stop?" he asked.
Eastgate responds: "For decades, parents were told by doctors, 'If you don't medicate your child, you're a bad parent.' But when children themselves report the drugs made them feel bad, it's psychiatry that refuses to listen."
In response to the widespread overuse of ADHD diagnoses and stimulant prescribing—even in children under five—the U.S. Department of Health and Human Services has launched a federal review. CCHR welcomes this as long overdue.
For over 40 years, CCHR has maintained that psychiatric labels such as ADHD are not rooted in biological science but are voted into existence through panels of psychiatrists—not discovered through medical testing. As far back as the 1980s and 1990s, CCHR was on record opposing the mass diagnosis of ADHD and the marketing of stimulants to schoolchildren.
"This investigation must look at how pseudoscience became policy," said Eastgate. "And why the system ignored watchdogs, parents, and even the United Nations, until some of the same researchers who created the mess began to admit their mistake."
In 2017, Dr. Dainius Pūras, a psychiatrist and then UN Special Rapporteur on the Right to Health, urged governments to move away from the biomedical (drug-based) model of mental health.[2] CCHR had already submitted evidence to the U.N. Committee on the Rights of the Child (UNCRC), documenting psychostimulant prescribing in 14 countries.
The UNCRC responded by recommending strict monitoring of ADHD drug use in children and criticized the "medicating" of children without addressing root causes or offering alternative supports.[3]
More recently, the World Health Organization and the Office of the U.N. High Commissioner for Human Rights jointly declared that "legislation on mental health must… move away from the narrow traditional 'biomedical paradigm.'"[4]
The New York Times exposé represents a landmark moment in pediatric mental health. It exposes how ADHD's "biological" foundations were misleading, and the harms of its treatments were undersold. CCHR says it validates what the group has long stood for: that millions of children were mislabeled and drugged.
"This is a reckoning," concludes Eastgate. "But it must become a reform. It's not enough to admit the science was wrong. The system must now be held accountable for what it did with that false science—and ensure it never happens again."
About CCHR: Mental health industry watchdog established in 1969 by the Church of Scientology and the late professor of psychiatry, Dr. Thomas Szasz. CCHR has achieved hundreds of reforms, including bans on minors being electroshocked and federal protections against forced drugging of schoolchildren.
Sources:
[1] Paul Tough, "Have We Been Thinking About A.D.H.D. All Wrong?" The New York Times Magazine, 13 Apr. 2025, www.nytimes.com/2025/04/13/magazine/adhd-medication-treatment-research.html?smid=em-share
[2] "World Needs 'Revolution' in Mental Health Care, U.N. Health Rights Expert Reports," CCHR International, 14 June 2017, www.cchrint.org/2017/06/14/world-needs-revolution-in-mental-health-care/; "World needs 'revolution' in mental health care – UN rights expert," United Nations, 6 June 2017, www.ohchr.org/en/press-releases/2017/06/world-needs-revolution-mental-health-care-un-rights-expert; web.archive.org/web/20170118053505/http://www.ohchr.org/EN/Issues/Health/Pages/SRBio.aspx
[3] "Consideration of reports submitted by States parties under article 44 of the Convention," UNCRC, 17 Sept. – 5 Oct. 2012, p. 15, web.archive.org/web/20130729192330/http://rightsofchildren.ca/wp-content/uploads/Canada_CRC-Concluding-Observations_61.2012.pdf
[4] "New WHO Mental Health Guideline Condemns Coercive Psychiatric Practices," CCHR International, 18 Sept. 2023, www.cchrint.org/2023/09/18/who-guideline-condemns-coercive-psychiatric-practices/; "Guidance on Mental Health, Human Rights and Legislation," World Health Organization, OHCHR, 9 Oct. 2023, p. xvii, iris.who.int/bitstream/handle/10665/373126/9789240080737-eng.pdf
Source: Citizens Commission on Human Rights International
Filed Under: Consumer, Family, Education, Health, Government, Citizens Commission On Human Rights, CCHR International
0 Comments
Latest on PrZen
- Award-winning NJ Author Celebrates New Release and Multi-Author Collaboration
- Therapy 911 Launches Mental Health Social Network to Celebrate Mental Health Awareness Month
- Bosco's Beach Launches Vacation Rentals in Panama City Beach, Florida
- $7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- One Park Financial Once Again Honored with Sun Sentinel's Top Workplaces Award for the 8th Time — Achieves Best Ranking Yet in 2025
- Cycurion Wins $33M Cybersecurity Contract for State Colleges, Also $6M from Transportation Agency: Cycurion, Inc. (Stock Symbol: CYCU) is Undervalued
- Novel 'We Won't Go Back' Published; Addresses Women's Issues
- Call for Papers Deadline Approaching – Don't Miss Your Shot to Speak at the OpenSSL Conference 2025!
- The ROS1ders Announces Recipients of 2024 ROS1+ Cancer Innovation Awards
- AUACOM Signs a Statement of Shared Interest with BMCC
- WWSG Announces Exclusive Speaking Partnership with Patrick McGee, Author of 'Apple in China'
- Multi-Billion Dollar Drone Cleaning Market Addressed via New UAE Office, AI Drone and Quantum Computing Solutions in Varied Industries ZenaTech, Inc
- Spac Recovery Co. Files $590 Million Lawsuit Against Blackstone Products, Nomura , Franklin Square, Oaktree et al
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Sparking Disruptive Innovation in Web3
- Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
- Tribeca Film Festival Official Podcast Selection Lead Features Hollywood Stars, Focuses On Ending Childhood Lead Poisoning In New York!
- Industrial Parts Fittings Champions the Revival of American Manufacturing
- $34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
- Pikmykid Launches $100,000 School Safety Grant Giveaway to Support K–12 Schools Across the U.S
- Slotozilla Data Report: Unveiling 2024's Gaming Statistics